
pmid: 24936913
Progestogens are a promising treatment in the prevention of spontaneous preterm birth in high-risk women. In women with a prior history of spontaneous preterm delivery and in women with a sonographic shortened cervix, there is considerable evidence supporting a benefit of progestogen therapy in the reduction of preterm delivery. In women with multifetal gestations, progestogen therapy has not been shown to be beneficial. Data are inconclusive in women with arrested preterm labor. Questions remain about the mechanism of progestogen action, the optimal type of progestogen, the best mode of administration, and the ideal dosing regimen.
Pregnancy, High-Risk, Administration, Oral, Drug Administration Schedule, Administration, Intravaginal, Obstetric Labor, Premature, Cervical Length Measurement, Pregnancy, Risk Factors, Humans, Premature Birth, Female, Pregnancy, Multiple, Progestins, Progesterone
Pregnancy, High-Risk, Administration, Oral, Drug Administration Schedule, Administration, Intravaginal, Obstetric Labor, Premature, Cervical Length Measurement, Pregnancy, Risk Factors, Humans, Premature Birth, Female, Pregnancy, Multiple, Progestins, Progesterone
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
